MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 85 filers reported holding MUSTANG BIO INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44,000 | -6.4% | 120,000 | 0.0% | 0.00% | – |
| Q4 2022 | $47,000 | -16.1% | 120,000 | 0.0% | 0.00% | – |
| Q3 2022 | $56,000 | -20.0% | 120,000 | 0.0% | 0.00% | – |
| Q2 2022 | $70,000 | -42.1% | 120,000 | 0.0% | 0.00% | – |
| Q1 2022 | $121,000 | -39.2% | 120,000 | 0.0% | 0.00% | – |
| Q4 2021 | $199,000 | -38.4% | 120,000 | 0.0% | 0.00% | – |
| Q3 2021 | $323,000 | -18.8% | 120,000 | 0.0% | 0.00% | – |
| Q2 2021 | $398,000 | 0.0% | 120,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $398,000 | -12.3% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $454,000 | +20.1% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $378,000 | -1.0% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $382,000 | +18.6% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $322,000 | -34.3% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $490,000 | +25.3% | 120,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $391,000 | -70.5% | 120,000 | -66.7% | 0.00% | 0.0% |
| Q2 2019 | $1,326,000 | – | 360,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 224,192 | $706,000 | 1.53% |
| Endurant Capital Management LP | 1,423,050 | $4,483,000 | 1.33% |
| FNY Investment Advisers, LLC | 300,000 | $945,000 | 0.40% |
| Ikarian Capital, LLC | 806,475 | $2,541,000 | 0.18% |
| 683 Capital Management, LLC | 460,000 | $1,449,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 150,241 | $473,000 | 0.08% |
| ALGERT GLOBAL LLC | 61,440 | $194,000 | 0.06% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 85,000 | $268,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 164,577 | $518,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 174,325 | $550,000 | 0.03% |